Abstract
Thyroid storm and myxedema coma are endocrine emergencies with high morbidity and mortality, where early recognition with a low index of suspicion and prompt treatment can significantly impact outcomes [1]. The diagnosis of thyroid storm is made clinically and cannot be based on laboratory abnormalities, and diagnostic criteria have been put forth by Burch and Wartofsky and by Akamizu et al. [2, 3]. Multidisciplinary care in a critical care setting is recommended, and identification of the precipitating cause and reversal or treatment of that cause should be sought if possible [1]. Medical treatment of thyroid storm involves understanding the pathophysiology underlying its development and then targeting all steps of thyroid hormone synthesis, release, and action in a specified order, along with supportive care [1]. Treatment should begin with thionamides (propylthiouracil/PTU preferred over methimazole), then iodine administration (potassium iodine or Lugol’s solution) or alternatively lithium, then cholestyramine to block the enterohepatic circulation of thyroid hormone, and beta-blockers (propranolol or esmolol), temperature regulation with cooling and antipyretics (Tylenol preferred over salicylates), intravenous fluid resuscitation for dehydration, and stress dose steroids (hydrocortisone) with vasopressors as needed. Therapeutic plasma exchange (TPE) or plasmapheresis can also be utilized. Finally, definitive therapy is surgery (subtotal or near-total thyroidectomy) or radioactive iodine ablation.
Myxedema coma is severe hypothyroidism, often with significant hypothermia, bradycardia, and mental status changes as substantial as a coma, often with a precipitating cause. Popoveniuc et al. [4] have proposed a diagnostic scoring system for myxedema coma. Medical treatment for myxedema coma involves thyroid hormone replacement (with T3 and/or T4), supportive care (warm ambient temperature and warming blankets, IV fluids including potentially hypertonic saline for hyponatremia, mechanical ventilation or other ventilation support, and hydrocortisone), and treatment of the precipitating cause and any other sequelae of myxedema coma including seizures. The mortality of both thyroid storm and myxedema coma has improved over the years with improvements in critical care.
References
Chiha M, Samarasinghe S, Kabaker AS. Thyroid storm: an updated review. J Intensive Care Med. 2015;30(3):131–40.
Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin N Am. 1993;22(2):263–77.
Akamizu T, Satoh T, Isozaki O, Suzuki A, Wakino S, Iburi T, et al. Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys. Thyroid. 2012;22(7):661–79.
Popoveniuc G, Chandra T, Sud A, Sharma M, Blackman MR, Burman KD, et al. A diagnostic scoring system for myxedema coma. Endocr Pract. 2014;20(8):808–17.
Lahey FH. Apathetic thyroidism. Ann Surg. 1931;93(5):1026–30.
Feldt-Rasmussen U, Emerson CH. Further thoughts on the diagnosis and diagnostic criteria for thyroid storm. Thyroid. 2012;22(11):1094–5.
American Thyroid A. General information/press room. 2015 [cited 2015 July 1, 2015]. Available from: http://www.thyroid.org/media-main/about-hypothyroidism/.
Nayak B, Burman K. Thyrotoxicosis and thyroid storm. Endocrinol Metab Clin N Am. 2006;35(4):663–86.
Wartofsky L. Thyrotoxic storm. In: Braverman L, Utiger R, editors. Werner and Ingbar’s the thyroid. 8th ed. Philadelphia: Lippincott Williams and Wilkins; 2000.
Stathatos N, Wartofsky L. Thyrotoxic storm. J Intensive Care Med. 2002;17(1):1–7.
Sarlis NJ, Gourgiotis L. Thyroid emergencies. Rev Endocr Metab Disord. 2003;4(2):129–36.
Byrum D, Kirkwood PL. Pituitary, thyroid, and adrenal disorders. In: Carlson KK, editor. Advanced critical care nursing. St. Louis: Saunders Elsevier; 2009. p. 951–7.
Waltman PA, Brewer JM, Lobert S. Thyroid storm during pregnancy a medical emergency. Crit Care Nurse. 2004;24(2):74–9.
Dillmann WH. Thyroid storm. Curr Ther Endocrinol Metab. 1997;6:81–5.
Klubo-Gwiezdzinska J, Wartofsky L. Thyroid emergencies. Med Clin N Am. 2012;96(2):385–403.
Rodríguez I, Fluiters E, Pérez-Méndez LF, Luna R, Páramo C, García-Mayor RV. Factors associated with mortality of patients with myxoedema coma: prospective study in 11 cases treated in a single institution. J Endocrinol. 2004;180(2):347–50.
Wartofsky L. Myxedema coma. Endocrinol Metab Clin N Am. 2006;35(4):687–98.
Dutta P, Bhansali A, Masoodi SR, Bhadada S, Sharma N, Rajput R. Predictors of outcome in myxoedema coma: a study from a tertiary care centre. Crit Care. 2008;12(1):R1.
Hampton J. Thyroid gland disorder emergencies: thyroid storm and myxedema coma. AACN Adv Crit Care. 2013;24(3):325–32.
Kwaku MP, Burman KD. Myxedema coma. J Intensive Care Med. 2007;22(4):224–31.
Davies TF, Larsen PR. Williams textbook of endocrinology. 11th ed. Philadelphia: Saunders Elsevier; 2007.
Holcomb SS. Thyroid diseases: a primer for the critical care nurse. Dimens Crit Care Nurs. 2002;21(4):127–33.
Ringel MD. Management of hypothyroidism and hyperthyroidism in the intensive care unit. Crit Care Clin. 2001;17(1):59–74.
Tietgens ST, Leinung MC. Thyroid storm. Med Clin N Am. 1995;79(1):169–84.
Brooks MH, Waldstein SS. Free thyroxine concentrations in thyroid storm. Ann Intern Med. 1980;93(5):694–7.
Carhill A, Gutierrez A, Lakhia R, Nalini R. Surviving the storm: two cases of thyroid storm successfully treated with plasmapheresis. BMJ Case Reports. 2012;2012. Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=carhill+lakhia.
Coulombe P, Dussault JH, Letarte J, Simmard SJ. Catecholamines metabolism in thyroid diseases. I. Epinephrine secretion rate in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab. 1976;42(1):125–31.
Coulombe P, Dussault JH, Walker P. Catecholamine metabolism in thyroid disease. II. Norepinephrine secretion rate in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab. 1977;44(6):1185–9.
Bilezikian JP, Loeb JN. The influence of hyperthyroidism and hypothyroidism on alpha- and beta-adrenergic receptor systems and adrenergic responsiveness. Endocr Rev. 1983;4(4):378–88.
Silva JE, Bianco SD. Thyroid-adrenergic interactions: physiological and clinical implications. Thyroid. 2008;18(2):157–65.
Jameson JL, Weetman AP. Disorders of the thyroid gland. Harrison’s endocrinology. New York: McGraw-Hill; 2006. p. 70–711.
Mariash CN. The thyroid gland. In: Niewoehner CB, editor. Endocrine pathophysiology. Raleigh: Hayes Barton Press; 2004. p. 52–83.
Naito Y, Sone T, Kataoka K, Sawada M, Yamazaki K. Thyroid storm due to functioning metastatic thyroid carcinoma in a burn patient. Anesthesiology. 1997;87(2):433–5.
Lin YQ, Wang X, Murthy MS, Agarwala S. Life-threatening thyrotoxicosis induced by combination therapy with PEG-interferon and ribavirin in chronic hepatitis C. Endocr Pract. 2005;11(2):135–9.
Lee HL, Yu E, Guo HR. Simultaneous presentation of thyroid storm and diabetic ketoacidosis. Am J Emerg Med. 2001;19(7):603–4.
Yoon SJ, Kim DM, Kim JU, Kim KW, Ahn CW, Cha BS, et al. A case of thyroid storm due to thyrotoxicosis factitia. Yonsei Med J. 2003;44(2):351–4.
Moskovitz JB, Bond MC. Molar pregnancy-induced thyroid storm. J Emerg Med. 2010;38(5):e71–6.
Baharoon SA. H1N1 infection-induced thyroid storm. Ann Thorac Med. 2010;5(2):110–2.
Vora NM, Fedok F, Stack BC. Report of a rare case of trauma-induced thyroid storm. Ear Nose Throat J. 2002;81(8):570–2, 4.
Swinburne JL, Kreisman SH. A rare case of subacute thyroiditis causing thyroid storm. Thyroid. 2007;17(1):73–6.
Clark OH, Duh Q-Y, Kebebew E. Textbook of endocrine surgery. 2nd ed. Philadelphia: Elsevier Saunders; 2005.
Wartofsky L. Clinical criteria for the diagnosis of thyroid storm. Thyroid. 2012;22(7):659–60.
Martinez-Diaz GJ, Formaker C, Hsia R. Atrial fibrillation from thyroid storm. J Emerg Med. 2012;42(1):e7–9.
Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725–35.
Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344(7):501–9.
Ngo SY, Chew HC. When the storm passes unnoticed – a case series of thyroid storm. Resuscitation. 2007;73(3):485–90.
Carroll R, Matfin G. Endocrine and metabolic emergencies: thyroid storm. Ther Adv Endocrinol Metab. 2010;1(3):139–45.
Choudhary AM, Roberts I. Thyroid storm presenting with liver failure. J Clin Gastroenterol. 1999;29(4):318–21.
Deng Y, Zheng W, Zhu J. Successful treatment of thyroid crisis accompanied by hypoglycemia, lactic acidosis, and multiple organ failure. Am J Emerg Med. 2012;30(9):e2094–6.
Harwood-Nuss AL, Martel TJ. An unusual cause of abdominal pain in a young woman. Ann Emerg Med. 1991;20(5):574–82.
Lee TG, Ha CK, Lim BH. Thyroid storm presenting as status epilepticus and stroke. Postgrad Med J. 1997;73(855):61.
Hosojima H, Iwasaki R, Miyauchi E, Okada H, Morimoto S. Rhabdomyolysis accompanying thyroid crisis: an autopsy case report. Intern Med. 1992;31(10):1233–5.
Cooper DS. Antithyroid drugs. N Engl J Med. 2005;352(9):905–17.
Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract. 2011;17(3):456–520.
Alfadhli E, Gianoukakis AG. Management of severe thyrotoxicosis when the gastrointestinal tract is compromised. Thyroid. 2011;21(3):215–20.
Nabil N, Miner DJ, Amatruda JM. Methimazole: an alternative route of administration. J Clin Endocrin Metab. 1982;54(1):180–1.
Bartle WR, Walker SE, Silverberg JD. Rectal absorption of propylthiouracil. Int J Clin Pharmacol Ther Toxicol. 1988;26(6):285–7.
Jongjaroenprasert W, Akarawut W, Chantasart D, Chailurkit L, Rajatanavin R. Rectal administration of propylthiouracil in hyperthyroid patients: comparison of suspension enema and suppository form. Thyroid. 2002;12(7):627–31.
Hodak SP, Huang C, Clarke D, Burman KD, Jonklaas J, Janicic-Kharic N. Intravenous methimazole in the treatment of refractory hyperthyroidism. Thyroid. 2006;16(7):691–5.
Eng PH, Cardona GR, Fang SL, Previti M, Alex S, Carrasco N, et al. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology. 1999;140(8):3404–10.
Yeung SC, Go R, Balasubramanyam A. Rectal administration of iodide and propylthiouracil in the treatment of thyroid storm. Thyroid. 1995;5(5):403–5.
Ogiso S, Inamoto S, Hata H, Yamaguchi T, Otani T, Koizumi K. Successful treatment of gastric perforation with thyrotoxic crisis. Am J Emerg Med. 2008;26(9):1063–5.
Woeber KA. Iodine and thyroid disease. Med Clin N Am. 1991;75(1):169–78.
Wartofsky L, Ransil BJ, Ingbar SH. Inhibition by iodine of the release of thyroxine from the thyroid glands of patients with thyrotoxicosis. J Clin Investig. 1970;49(1):78–86.
Langley RW, Burch HB. Perioperative management of the thyrotoxic patient. Endocrin Metab Clin N Am. 2003;32(2):519–34.
Panzer C, Beazley R, Braverman L. Rapid preoperative preparation for severe hyperthyroid Graves’ disease. J Clin Endocrinol Metab. 2004;89(5):2142–4.
Roti E, Robuschi G, Gardini E, Montermini M, Salvi M, Manfredi A, et al. Comparison of methimazole, methimazole and sodium ipodate, and methimazole and saturated solution of potassium iodide in the early treatment of hyperthyroid Graves’ disease. Clin Endocrinol. 1988;28(3):305–14.
Kaykhaei MA, Shams M, Sadegholvad A, Dabbaghmanesh MH, Omrani GR. Low doses of cholestyramine in the treatment of hyperthyroidism. Endocrine. 2008;34(1–3):52–5.
Tsai WC, Pei D, Wang TF, Wu DA, Li JC, Wei CL, et al. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves’ hyperthyroidism. Clin Endocrinol. 2005;62(5):521–4.
Mercado M, Mendoza-Zubieta V, Bautista-Osorio R, Espinoza-de los Monteros AL. Treatment of hyperthyroidism with a combination of methimazole and cholestyramine. J Clin Endocrinol Metab. 1996;81(9):3191–3.
Hughes G. Management of thyrotoxic crises with a beta-adrenergic blocking agent (Pronethalol). Br J Clin Pract. 1966;20(11):579–81.
Duggal J, Singh S, Kuchinic P, Butler P, Arora R. Utility of esmolol in thyroid crisis. Can J Clin Pharmacol. 2006;13(3):e292–5.
Wang R, Nelson JC, Wilcox RB. Salsalate and salicylate binding to and their displacement of thyroxine from thyroxine-binding globulin, transthyretin, and albumin. Thyroid. 1999;9(4):359–64.
Tsatsoulis A, Johnson EO, Kalogera CH, Seferiadis K, Tsolas O. The effect of thyrotoxicosis on adrenocortical reserve. Eur J Endocrinol. 2000;142(3):231–5.
Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, et al. Guidelines on the use of therapeutic apheresis in clinical practice – evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher. 2010;25(3):83–177.
Ezer A, Caliskan K, Parlakgumus A, Belli S, Kozanoglu I, Yildirim S. Preoperative therapeutic plasma exchange in patients with thyrotoxicosis. J Clin Apher. 2009;24(3):111–4.
Ashkar FS, Katims RB, Smoak 3rd WM, Gilson AJ. Thyroid storm treatment with blood exchange and plasmapheresis. J Am Med Assoc. 1970;214(7):1275–9.
Muller C, Perrin P, Faller B, Richter S, Chantrel F. Role of plasma exchange in the thyroid storm. Ther Apher Dial. 2011;15(6):522–31.
Chen JH, Yeh JH, Lai HW, Liao CS. Therapeutic plasma exchange in patients with hyperlipidemic pancreatitis. World J Gastroenterol. 2004;10(15):2272–4.
Scholz GH, Hagemann E, Arkenau C, Engelmann L, Lamesch P, Schreiter D, et al. Is there a place for thyroidectomy in older patients with thyrotoxic storm and cardiorespiratory failure? Thyroid. 2003;13(10):933–40.
Pandey CK, Raza M, Dhiraaj S, Agarwal A, Singh PK. Rapid preparation of severe uncontrolled thyrotoxicosis due to Graves’ disease with Iopanoic acid – a case report. Can J Anaesth. 2004;51(1):38–40.
Roizen M, Becker CE. A review of cases at University of California, San Francisco. Calif Med. 1971;115(4):5–9.
Myers L, Hays J. Myxedema coma. Crit Care Clin. 1991;7(1):43–56.
Nicoloff JT, LoPresti JS. Myxedema coma. A form of decompensated hypothyroidism. Endocrinol Metab Clin N Am. 1993;22(2):279–90.
Jordan RM. Myxedema coma. Pathophysiology, therapy, and factors affecting prognosis. Med Clin N Am. 1995;79(1):185–94.
Mathew V, Misgar RA, Ghosh S, Mukhopadhyay P, Roychowdhury P, Pandit K, et al. Myxedema coma: a new look into an old crisis. J Thyroid Res. 2011;2011:493462.
Zwillich CW, Pierson DJ, Hofeldt FD, Lufkin EG, Weil JV. Ventilatory control in myxedema and hypothyroidism. N Engl J Med. 1975;292(13):662–5.
Manfredi E, van Zaane B, Gerdes VE, Brandjes DP, Squizzato A. Hypothyroidism and acquired von Willebrand’s syndrome: a systematic review. Haemophilia. 2008;14(3):423–33.
Patel S, Robinson S, Bidgood RJ, Edmonds CJ. A pre-eclamptic-like syndrome associated with hypothyroidism during pregnancy. Q J Med. 1991;79(289):435–41.
Blignault EJ. Advanced pregnancy in a severely myxoedematous patient: a case report and review of the literature. S Afr Med J. 1980;57(25):1050–1.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Grant, S.B., Trooskin, S.Z. (2016). Thyroid Disorders. In: Martin, N.D., Kaplan, L.J. (eds) Principles of Adult Surgical Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-33341-0_31
Download citation
DOI: https://doi.org/10.1007/978-3-319-33341-0_31
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33339-7
Online ISBN: 978-3-319-33341-0
eBook Packages: MedicineMedicine (R0)